Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment
AUTOR(ES)
Falcao, Felipe Jose de Andrade, Alves, Claudia Maria Rodrigues, Barbosa, Adriano Henrique Pereira, Caixeta, Adriano, Sousa, Jose Marconi Almeida, Souza, Jose Augusto Marcondes, Amaral, Amaury, Wilke, Luiz Carlos, Perez, Fatima Cristina A., Goncalves Junior, Iran, Stefanini, Edson, Carvalho, Antonio Carlos
FONTE
Clinics
DATA DE PUBLICAÇÃO
2013-12
RESUMO
OBJECTIVES: To identify predictors of in-hospital mortality in patients with acute myocardial infarction undergoing pharmacoinvasive treatment. METHODS: This was an observational, prospective study that included 398 patients admitted to a tertiary center for percutaneous coronary intervention within 3 to 24 hours after thrombolysis with tenecteplase. ClinicalTrials.gov: NCT01791764 RESULTS: The overall in-hospital mortality rate was 5.8%. Compared with patients who survived, patients who died were more likely to be older, have higher rates of diabetes and chronic renal failure, have a lower left ventricular ejection fraction, and demonstrate more evidence of heart failure (Killip class III or IV). Patients who died had significantly lower rates of successful thrombolysis (39% vs. 68%; p = 0.005) and final myocardial blush grade 3 (13.0% vs. 61.9%; p<0.0001). Based on the multivariate analysis, the Global Registry of Acute Coronary Events score (odds ratio 1.05, 95% confidence interval (CI) 1.02-1.09; p = 0.001), left ventricular ejection fraction (odds ratio 0.9, 95% CI 0.89-0.97; p = 0.001), and final myocardial blush grade of 0-2 (odds ratio 8.85, 95% CI 1.34-58.57; p = 0.02) were independent predictors of mortality. CONCLUSIONS: In this prospective study that evaluated patients with ST-segment elevation myocardial infarction treated by a pharmacoinvasive strategy, the in-hospital mortality rate was 5.8%. The Global Registry of Acute Coronary Events score, left ventricular ejection fraction, and myocardial blush were independent predictors of mortality in this high-risk group of acute coronary syndrome patients.
Documentos Relacionados
- Biomarkers and Mortality in ST-Segment Elevation Myocardial Infarction
- Predictors of left ventricular ejection function decline in young patients with ST-segment elevation myocardial infarction
- New-Onset Atrial Fibrillation in St-Segment Elevation Myocardial Infarction: Predictors and Impact on Therapy And Mortality
- Fibrinolytic therapy for acute ST-segment elevation myocardial infarction
- Fibrinolytic therapy for acute ST-segment elevation myocardial infarction